Pharmaceutical

ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology

In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in oncology.

Oct 22, 2024 - 04:00
ImmunoPrecise touts potential of rabbit monoclonal antibodies in oncology
In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in oncology.
Read the original article

Tags:

Previous Article

Seaport raises $225m to advance portfolio of neuropsychiatric prodrugs

Next Article

FibroBiologics and Charles River link for chronic disease therapies manufacture

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AI insight at BIO, Google and Mayo Clinic’s latest effort, & $13 million for health workforce tech

AI insight at BIO, Google and Mayo Clinic’s latest effo...

Jun 8, 2023

Flu activity gaining steam in the U.S. as vaccination rates lag

Flu activity gaining steam in the U.S. as vaccination r...

Nov 17, 2023

EMA approves Bavarian Nordic’s mpox vaccine for teenagers

EMA approves Bavarian Nordic’s mpox vaccine for teenagers

Sep 22, 2024